Document:

Form of Restricted Stock Unit Grant Notice

 Exhibit 10.10 
 IRELAND 
 JAZZ PHARMACEUTICALS
PLC 
 2011 EQUITY INCENTIVE PLAN 

RESTRICTED STOCK UNIT GRANT NOTICE 

Jazz Pharmaceuticals plc (the “Company”) hereby awards to Participant the number of restricted stock units
(“RSUs”) specified and on the terms set forth below (the “Award”). The Award is subject to all of the terms and conditions as set forth herein and in the Company’s 2011 Equity Incentive Plan (the
“Plan”) and the Restricted Stock Unit Award Agreement (the “Award Agreement”), both of which are attached hereto and incorporated herein in their entirety. Capitalized terms not explicitly defined
herein but defined in the Plan or the Award Agreement shall have the meanings set forth in the Plan or the Award Agreement. Except as explicitly provided herein or in the Award Agreement, in the event of any conflict between the terms in the Award
and the Plan, the terms of the Plan shall control. 
  

			
	Participant:	 	 
	RSU#:	 	 
	Date of Grant:	 	 
	 Vesting Commencement Date:
	 	 
	Number of RSUs:	 	 
	Consideration:	 	 Participant’s Services

  

			
	Vesting Schedule:	  	[                             
                                         
      ]
		
	Issuance Schedule:	  	One Ordinary Share will be issued for each RSU which vests at the time set forth in Section 6 of the Award Agreement.

 Data Protection: The undersigned Participant acknowledges, and understands and agrees that, in signing this
Restricted Stock Unit Grant Notice he/she consents to the Company and any Affiliate sharing and exchanging his/her information held in order to administer and operate the Plan (including personal details, data relating to participation, salary,
taxation and employment and sensitive personal data e.g. data relating to physical or mental health, criminal conviction or the alleged commission of offences) (the “Information”) and Participant further
consents to the Company and any Affiliate providing the Company’s or Affiliates’ agents and/or third parties with the Information for the administration and operation of the Plan. Participant accepts that this may involve the Information
being sent to a country outside the European Economic Area which may not have the same level of data protection laws as Ireland. Participant acknowledges that he/she has the right to request a list of the names and addresses of any potential
recipients of the Information and to review and correct the Information by contacting the local human resources representative. Participant further acknowledges that the collection, processing and transfer of the Information is important to Plan
administration and that failure to consent to same may prohibit participation in the Plan. 
 Additional Terms/Acknowledgements:
The undersigned Participant acknowledges receipt of, and understands and agrees to, this Restricted Stock Unit Grant Notice, the Award Agreement and the Plan. Participant further acknowledges that as of the Date of Grant, this Restricted Stock Unit
Grant Notice, the Award Agreement and the Plan set forth the entire understanding between Participant and the Company regarding the Award and supersedes all prior oral and written agreements on that subject, with the exception of: (i) any
employment or severance arrangement that would provide for vesting acceleration of the Award upon the terms and conditions set forth therein and (ii) any compensation recovery policy that is adopted by the Company or is otherwise required by
applicable law. By accepting this Award, 

 IRELAND 

 
 
Participant consents to receive Plan documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another
third party designated by the Company. 
  

									
	JAZZ PHARMACEUTICALS PLC	 		 	PARTICIPANT:
				
	By:	 	 	 		 	 
		 	Signature	 		 		 	Signature
					
	Title:	 	 	 		 	Date:	 	 
					
	Date:	 	 	 		 		 	

 ATTACHMENTS: Award Agreement, 2011 Equity Incentive Plan 

 IRELAND 

 
 ATTACHMENT I 

RESTRICTED STOCK UNIT AWARD AGREEMENT 

 IRELAND 

 
 JAZZ PHARMACEUTICALS
PLC 
 2011 EQUITY INCENTIVE PLAN 

RESTRICTED STOCK UNIT AWARD AGREEMENT 

Pursuant to the Restricted Stock Unit Grant Notice (the “Grant Notice”) and this Restricted Stock Unit Award
Agreement (the “Agreement”) and in consideration of your services, Jazz Pharmaceuticals plc (the “Company”) has awarded you a Restricted Stock Unit Award (the “Award”) under its
2011 Equity Incentive Plan (the “Plan”) for the number of restricted stock units (the “RSUs”) set forth in the Grant Notice. Capitalized terms not explicitly defined in this Agreement shall have the
same meanings given to them in the Plan or the Grant Notice, as applicable. Except as otherwise explicitly provided herein, in the event of any conflict between the terms in this Agreement and the Plan, the terms of the Plan shall control.

 The details of your Award, in addition to those set forth in the Grant Notice and the Plan, are as follows. 

1. GRANT OF THE AWARD. This Award represents your right to be
issued on a future date the number of Ordinary Shares that is equal to the number of RSUs indicated in the Grant Notice. As of the Date of Grant, the Company will credit to a bookkeeping account maintained by the Company for your benefit (the
“Account”) the number of RSUs subject to the Award. This Award was granted in consideration of your services to the Company. Except as otherwise provided herein, you will not be required to make any payment to the Company
(other than past and future services to the Company) with respect to your receipt of the Award, the vesting of the RSUs or the delivery of the Ordinary Shares to be issued in respect of the Award; provided, however, that to the extent that
any Ordinary Shares issued upon settlement of your Award are newly issued Ordinary Shares, you must pay in cash or by check, bank draft or money order payable to the Company an amount equal to the par value of such number of newly issued Ordinary
Shares (rounded up to the nearest whole cent). 
 2. VESTING. Subject to Section 11 and the
limitations contained herein, your Award will vest, if at all, in accordance with the vesting schedule provided in the Grant Notice, provided that vesting will cease upon the termination of your Continuous Service. Upon such termination of your
Continuous Service, the RSUs credited to the Account that were not vested on the date of such termination will be forfeited at no cost to the Company and you will have no further right, title or interest in such RSUs or the Ordinary Shares to be
issued in respect of such portion of the Award. 
 3. NUMBER OF RSUS
AND ORDINARY SHARES. 
 (a) The number of RSUs subject to your Award may
be adjusted from time to time for Capitalization Adjustments, as provided in the Plan. 
 (b) Any additional RSUs that
become subject to the Award pursuant to this Section 3 shall be subject, in a manner determined by the Board, to the same forfeiture restrictions, restrictions on transferability, and time and manner of delivery as applicable to the other RSUs
covered by your Award. 

  
 1. 

 IRELAND 

 
 (c) Notwithstanding the provisions of this
Section 3, no fractional Ordinary Shares or rights for fractional Ordinary Shares shall be created pursuant to this Section 3. The Board shall, in its discretion, determine an equivalent benefit for any fractional Ordinary Shares or
fractional Ordinary Shares that might be created by the adjustments referred to in this Section 3. 
 4.
SECURITIES LAW COMPLIANCE. You may not be issued any Ordinary Shares in respect of your Award unless either (i) the Ordinary Shares are registered under the Securities Act; or (ii) the
Company has determined that such issuance would be exempt from the registration requirements of the Securities Act. Your Award also must comply with other applicable laws and regulations governing the Award, and you will not receive such Ordinary
Shares if the Company determines that such receipt would not be in material compliance with such laws and regulations. 
 5.
TRANSFER RESTRICTIONS. Your Award is not transferable, except to your legal personal representatives in the event of your death. In addition to any other limitation on transfer created by applicable
securities laws, you agree not to assign, hypothecate, donate, encumber or otherwise dispose of any interest in any of the Ordinary Shares subject to the Award until the Ordinary Shares are issued to you in accordance with Section 6 of this
Agreement. After the Ordinary Shares have been issued to you, you are free to assign, hypothecate, donate, encumber or otherwise dispose of any interest in such Ordinary Shares provided that any such actions are in compliance with the provisions
herein and applicable securities laws. 
 6. DATE OF ISSUANCE. 

 (a) The Company will deliver to you a number of Ordinary Shares equal to the number of vested RSUs subject to your
Award, including any additional RSUs received pursuant to Section 3 above that relate to those vested RSUs on the applicable vesting date(s). However, if a scheduled delivery date falls on a date that is not a business day, such delivery date
shall instead fall on the next following business day. Notwithstanding the foregoing, in the event that (i) you are subject to the Company’s Policy Regarding Stock Trading by Executive Officers, Directors and Other Designated Employees (or
any successor policy) (the “Policy”), the Company’s Policy Against Trading on the Basis of Inside Information, or you are otherwise prohibited from selling Ordinary Shares in the open market and any Ordinary Shares
covered by your Award are scheduled to be delivered on a day (the “Original Distribution Date”) that does not occur during an open “window period” applicable to you or a day on which you are permitted to sell
Ordinary Shares pursuant to a written plan that meets the requirements of Rule 10b5-1 under the Exchange Act, as determined by the Company in accordance with the Policy, or does not occur on a date when you are otherwise permitted to sell Ordinary
Shares in the open market, and (ii) the Company elects not to satisfy its tax withholding obligations by withholding Ordinary Shares from your distribution, then such Ordinary Shares shall not be delivered on such Original Distribution Date and
shall instead be delivered on the first business day of the next occurring open “window period” applicable to you pursuant to the Policy (regardless of whether you are still providing Continuous Service at such time) or the next business
day when you are not prohibited from selling Ordinary Shares in the open market. The form of such delivery of the Ordinary Shares (e.g., a share certificate or electronic entry evidencing such Ordinary Shares) shall be determined by the
Company. 

  
 2. 

 IRELAND 

 
 (b) Notwithstanding the foregoing, if you are or
become a U.S. taxpayer subject to Section 409A of the Code or any state law of similar effect, the provisions of Appendix A to this Agreement will apply instead of Section 6(a) above. 

7. DIVIDENDS. You shall receive no benefit or adjustment to your Award with respect to any cash dividend,
share dividend or other distribution that does not result from a Capitalization Adjustment as provided in the Plan; provided, however, that this sentence shall not apply with respect to any Ordinary Shares that are delivered to you in
connection with your Award after such Ordinary Shares have been delivered to you. 
 8. RESTRICTIVE
LEGENDS. The Ordinary Shares issued in respect of your Award shall be endorsed with appropriate legends determined by the Company. 
 9. AWARD NOT A SERVICE CONTRACT. 
 (a) Nothing in this Agreement (including, but not limited to, the vesting of your Award pursuant to the schedule set forth in Section 2 herein or the issuance of the Ordinary Shares in respect
of your Award), the Plan or any covenant of good faith and fair dealing that may be found implicit in this Agreement or the Plan shall: (i) confer upon you any right to continue in the employ of, or affiliation with, the Company or an
Affiliate; (ii) constitute any promise or commitment by the Company or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation or any other term or condition of employment or affiliation;
(iii) confer any right or benefit under this Agreement or the Plan unless such right or benefit has specifically accrued under the terms of this Agreement or Plan; or (iv) deprive the Company or an Affiliate of any right that it may have
to terminate you, subject to applicable law, and without regard to any future vesting opportunity that you may have. 

(b) By accepting this Award, you acknowledge and agree that the right to continue vesting in the Award pursuant to the schedule
set forth in Section 2 is earned only by providing Continuous Service (not through the act of being hired, being granted this Award or any other award or benefit) and that the Company has the right to reorganize, sell, spin-out or otherwise
restructure one or more of its businesses or Affiliates at any time or from time to time, as it deems appropriate (a “reorganization”). You further acknowledge and agree that such a reorganization could result in the termination of
your Continuous Service, or the termination of Affiliate status of your employer and the loss of benefits available to you under this Agreement, including but not limited to, the termination of the right to continue vesting in the Award. You further
acknowledge and agree that this Agreement, the Plan, the transactions contemplated hereunder and the vesting schedule set forth herein or any covenant of good faith and fair dealing that may be found implicit in any of them do not constitute an
express or implied promise of continued engagement as an employee or consultant for the term of this Agreement, for any period, or at all, and shall not interfere in any way with your right to terminate your Continuous Service at any time, or any
right the Company may have to terminate you, subject to applicable law. 

  
 3. 

 IRELAND 

 
 10. WITHHOLDING
OBLIGATIONS. 
 (a) On or before the time you receive a distribution of the Ordinary Shares subject to
your Award, or at any time thereafter as requested by the Company, you hereby authorize any required withholding from the Ordinary Shares issuable to you and/or otherwise agree to make adequate provision in cash for any sums required to satisfy the
tax and social security withholding obligations of the Company or any Affiliate which arise in connection with your Award (the “Withholding Taxes”). Additionally, the Company may, in its sole discretion, satisfy all or any
portion of the Withholding Taxes obligation relating to your Award by any of the following means or by a combination of such means: (i) withholding from any compensation otherwise payable to you by the Company; (ii) causing you to tender a
cash payment; or (iii) permitting or requiring you to enter into a “same day sale” commitment with a broker-dealer that is a member of the Financial Industry Regulatory Authority (a “FINRA Dealer”) whereby you
irrevocably elect to sell a portion of the Ordinary Shares to be delivered in connection with your RSUs to satisfy the Withholding Taxes and whereby the FINRA Dealer irrevocably commits to forward the proceeds necessary to satisfy the Withholding
Taxes directly to the Company and/or its Affiliates. 
 (b) Unless the tax and social security withholding obligations of
the Company and/or any Affiliate are satisfied, the Company shall have no obligation to deliver to you any Ordinary Shares. 

(c) In the event the Company’s obligation to withhold arises prior to the delivery to you of Ordinary Shares or it is
determined after the delivery of Ordinary Shares to you that the amount of the Company’s withholding obligation was greater than the amount withheld by the Company, you agree to indemnify and hold the Company harmless from any failure by the
Company to withhold the proper amount. 
 11. CHANGE IN
CONTROL. 
 (a) If your Continuous Service terminates either within twelve
(12) months following or one (1) month prior to the effective date of a Change in Control due to an Involuntary Termination Without Cause, the vesting of the RSUs subject to this Award shall be accelerated in full. In order to give effect
to the intent of this provision, in the event of your Involuntary Termination Without Cause, notwithstanding anything to the contrary set forth in the Plan or Section 2 of this Agreement, in no event will any portion of this Award be forfeited
or terminate any earlier than one (1) month following such termination date. 
 (b) For purposes of this Agreement,
“Involuntary Termination Without Cause” means the involuntary termination of your Continuous Service for reasons other than death, Disability, or Cause. For this purpose, “Cause” means the occurrence of any of the
following events that has a material negative impact on the business or reputation of the Company or an Affiliate: (i) your conviction for any criminal offence (other than an offence under any road traffic legislation in Ireland, the United
Kingdom or elsewhere for which a fine or 

  
 4. 

 IRELAND 

 
 
non-custodial penalty is imposed) or any offence under any regulation or legislation relating to insider dealing, fraud or dishonesty; (ii) your attempted commission of, or participation in,
a fraud or act of dishonesty against the Company or an Affiliate; (iii) your intentional, material violation of any contract or agreement between you and the Company or an Affiliate, or of any statutory duty owed to the Company or an Affiliate;
(iv) your unauthorized use or disclosure of the Company’s or an Affiliate’s confidential information or trade secrets; or (v) your gross misconduct. The determination that a termination of your Continuous Service is either for
Cause or without Cause shall be made by the Company (or an Affiliate, if applicable) in its sole discretion. Any determination by the Company (or an Affiliate, if applicable) that your Continuous Service was terminated by reason of dismissal without
Cause for the purposes of this Agreement shall have no effect upon any determination of the rights or obligations of you or the Company for any other purpose. 
 12. UNSECURED OBLIGATION. Your Award is unfunded, and as a holder of a vested Award, you shall be considered an unsecured creditor of the Company with respect
to the Company’s obligation, if any, to issue Ordinary Shares pursuant to this Agreement. You shall not have voting or any other rights as a shareholder of the Company with respect to the Ordinary Shares to be issued pursuant to this Agreement
until such Ordinary Shares are issued to you pursuant to Section 6 of this Agreement. Upon such issuance, you will obtain full voting and other rights as a shareholder of the Company. Nothing contained in this Agreement, and no action taken
pursuant to its provisions, shall create or be construed to create a trust of any kind or a fiduciary relationship between you and the Company or any other person. 
 13. OTHER DOCUMENTS. You hereby acknowledge receipt or the right to receive a document providing the information required by Rule 428(b)(1) promulgated under
the Securities Act, which includes the Plan prospectus. In addition, you acknowledge receipt of the Company’s policy permitting officers and directors to sell Ordinary Shares only during certain “window” periods and the Company’s
insider trading policy, in effect from time to time. 
 14. NOTICES. Any notices provided for in
your Award or the Plan shall be given in writing (including electronically) and shall be deemed effectively given upon receipt or, in the case of notices delivered by the Company to you, fourteen (14) days after deposit in the United States
mail, postage prepaid, addressed to you at the last address you provided to the Company. Notwithstanding the foregoing, the Company may, in its sole discretion, decide to deliver any documents related to participation in the Plan and this Award by
electronic means or to request your consent to participate in the Plan by electronic means. By accepting this Award you consent to receive such documents by electronic delivery and, if requested, to agree to participate in the Plan through an
on-line or electronic system established and maintained by the Company or another third party designated by the Company. 

15. MISCELLANEOUS. 
 (a) The rights and obligations of the Company under your Award shall be transferable to any one or more persons or entities, and all covenants and agreements hereunder shall inure to the benefit
of, and be enforceable by the Company’s successors and assigns. Your rights and obligations under your Award may only be assigned with the prior written consent of the Company. 

  
 5. 

 IRELAND 

 
 (b) You agree upon request to execute any further
documents or instruments necessary or desirable in the sole determination of the Company to carry out the purposes or intent of your Award. 
 (c) You acknowledge and agree that you have reviewed your Award in its entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting your Award, and fully
understand all provisions of your Award. 
 (d) This Agreement shall be subject to all applicable laws, rules, and
regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required. 

(e) All obligations of the Company under the Plan and this Agreement shall be binding on any successor to the Company, whether the
existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company. 

16. GOVERNING PLAN DOCUMENT. Your Award is subject to all the provisions of
the Plan, the provisions of which are hereby made a part of your Award, and is further subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan. Except as expressly
provided in this Agreement, in the event of any conflict between the provisions of your Award and those of the Plan, the provisions of the Plan shall control. In addition, your Award (and any compensation paid or Ordinary Shares issued under your
Award) is subject to recoupment in accordance with the Dodd–Frank Wall Street Reform and Consumer Protection Act and any implementing regulations thereunder, any clawback policy adopted by the Company and any compensation recovery policy
otherwise required by applicable law. 
 17. SEVERABILITY. If all or any part of this Agreement or
the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any portion of this Agreement or the Plan not declared to be unlawful or invalid. Any Section of this
Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful
and valid. 
 18. EFFECT ON OTHER EMPLOYEE
BENEFIT PLANS. The value of the Award subject to this Agreement shall not be included as compensation, earnings, salaries, or other similar terms used when calculating the Employee’s benefits under any employee
benefit plan sponsored by the Company or any Affiliate, except as such plan otherwise expressly provides. The Company expressly reserves its rights to amend, modify, or terminate any of the Company’s or any Affiliate’s employee benefit
plans. 
 19. AMENDMENT. This Agreement may not be modified, amended or terminated except by an
instrument in writing, signed by you and by a duly authorized representative of the Company. Notwithstanding the foregoing, this Agreement may be amended solely by the Board by a writing which specifically states that it is amending this Agreement,
so long as a copy of such amendment is delivered to you, and provided that no such amendment adversely affecting 

  
 6. 

 IRELAND 

 
 
your rights hereunder may be made without your written consent; provided, however, that notwithstanding the foregoing or anything in the Plan to the contrary and to the extent permitted by
applicable law, you hereby acknowledge and agree that this Agreement may be amended without your consent if the Board determines, in its discretion, that such amendment is necessary for legal, regulatory or tax reasons due to a change in the entity
for which you render service. Without limiting the foregoing, the Board reserves the right to change, by written notice to you, the provisions of this Agreement in any way it may deem necessary or advisable to carry out the purpose of the grant as a
result of any change in applicable laws or regulations or any future law, regulation, ruling, or judicial decision, provided that any such change shall be applicable only to rights relating to that portion of the Award which is then subject to
restrictions as provided herein. 
 20. HEADINGS. The headings of the Sections in this Agreement
are inserted for convenience only and shall not be deemed to constitute a part of this Agreement or to affect the meaning of this Agreement. 
 21. NO OBLIGATION TO MINIMIZE TAXES. The Company has no duty or obligation to minimize the tax consequences to you
of this Award and will not be liable to you for any adverse tax consequences to you arising in connection with this Award. You are hereby advised to consult with your own personal tax, financial and/or legal advisors regarding the tax consequences
of this Award and by signing the Grant Notice, you have agreed that you have done so or knowingly and voluntarily declined to do so. 
 *            *            * 

This Restricted Stock Unit Award Agreement will be deemed to be signed by you upon the signing by you of the Restricted Stock Unit Grant
Notice to which it is attached. 

  
 7. 

 IRELAND 

 
 Appendix A 

The provisions set forth in this Appendix A shall apply and replace Section 6 in the Agreement to the extent you are or become a U.S. taxpayer
subject to Section 409A of the Code or any state law of similar effect. 
 6. DATE OF
ISSUANCE.  
 (a) To the extent your Award is exempt from application of Section 409A of
the Code and any state law of similar effect (collectively “Section 409A”), the Company will deliver to you a number of Ordinary Shares equal to the number of vested RSUs subject to your Award, including any additional RSUs
received pursuant to Section 3 above that relate to those vested RSUs on the applicable vesting date(s). However, if a scheduled delivery date falls on a date that is not a business day, such delivery date shall instead fall on the next
following business day. Notwithstanding the foregoing, in the event that (i) you are subject to the Company’s Policy Regarding Stock Trading by Officers, Directors and Other Designated Employees (or any successor policy) (the
“Policy”) or you are otherwise prohibited from selling Ordinary Shares in the open market and any Ordinary Shares covered by your Award are scheduled to be delivered on a day (the “Original Distribution
Date”) that does not occur during an open “window period” applicable to you or a day on which you are permitted to sell Ordinary Shares pursuant to a written plan that meets the requirements of Rule 10b5-1 under the Exchange
Act, as determined by the Company in accordance with the Policy, or does not occur on a date when you are otherwise permitted to sell Ordinary Shares in the open market, and (ii) the Company elects not to satisfy its tax withholding obligations
by withholding Ordinary Shares from your distribution, then such Ordinary Shares shall not be delivered on such Original Distribution Date and shall instead be delivered on the first business day of the next occurring open “window period”
applicable to you pursuant to the Policy (regardless of whether you are still providing Continuous Service at such time) or the next business day when you are not prohibited from selling Ordinary Shares in the open market, but in no event later than
the fifteenth (15th) day of the third calendar month of the calendar year following the calendar year in which the Ordinary Shares covered by the Award vest. Delivery of the Ordinary Shares pursuant to the provisions of this Section 6(a)
is intended to comply with the requirements for the short-term deferral exemption available under Treasury Regulations Section 1.409A-1(b)(4) and shall be construed and administered in such manner. The form of such delivery of the Ordinary
Shares (e.g., a share certificate or electronic entry evidencing such Ordinary Shares) shall be determined by the Company. 
 (b) The provisions of this Section 6(b) are intended to apply to the extent your Award is subject to Section 409A because of the terms of a severance arrangement or other agreement
between you and the Company, if any, that provide for acceleration of vesting of your Award upon your termination of employment or separation from service (as such term is defined in Section 409A(a)(2)(A)(i) of the Code (and without regard to
any alternative definition thereunder)) (“Separation from Service”) and such severance benefit does not satisfy the requirements for an exemption from application of Section 409A provided under Treasury Regulations
Section 1.409A-1(b)(4) or 1.409A-1(b)(9) (“Non-Exempt Severance Arrangement”). To the extent your Award is subject to and not exempt from application of Section 409A due to application of a Non-Exempt Severance
Arrangement, the following provisions in this Section 6(b) shall supersede anything to the contrary in Section 6(a). 

  
 8. 

 IRELAND 

 
 (i) If your Award vests in the
ordinary course during your Continuous Service in accordance with the vesting schedule set forth in the Grant Notice, without accelerating vesting under the terms of a Non-Exempt Severance Arrangement, in no event will the Ordinary Shares be issued
in respect of your Award any later than the later of: (A) December 31st of the calendar year that includes the applicable vesting date and (B) the 60th day that follows the applicable vesting date. 

(ii) If vesting of your Award accelerates under the terms of a Non-Exempt Severance Arrangement in connection
with your Separation from Service, and such vesting acceleration provisions were in effect as of the Date of Grant of your Award and, therefore, are part of the terms of your Award as of the Date of Grant, then the Ordinary Shares will be earlier
issued in respect of your Award upon your Separation from Service in accordance with the terms of the Non-Exempt Severance Arrangement, but in no event later than the 60th day that follows the date of your Separation from Service. However, if at the time the Ordinary Shares would otherwise
be issued you are subject to the distribution limitations contained in Section 409A applicable to “specified employees,” as defined in Section 409A(a)(2)(B)(i) of the Code, such Ordinary Shares shall not be issued before the date
that is six (6) months following the date of your Separation from Service, or, if earlier, the date of your death that occurs within such six (6) month period. 
 (iii) If vesting of your Award accelerates under the terms of a Non-Exempt Severance Arrangement in connection with your Separation from Service, and such vesting acceleration provisions were not
in effect as of the date of grant of the Award and, therefore, are not a part of the terms of your Award on the date of grant, then such acceleration of vesting of your Award shall not accelerate the issuance date of the Ordinary Shares, but the
Ordinary Shares shall instead be issued on the same schedule as set forth in the Grant Notice as if they had vested in the ordinary course during your Continuous Service, notwithstanding the vesting acceleration of the Award. Such issuance schedule
is intended to satisfy the requirements of payment on a specified date or pursuant to a fixed schedule, as provided under Treasury Regulations Section 1.409A-3(a)(4). 
 (c) If your Award is subject to and not exempt from Section 409A (a “Non-Exempt Award”), then the provisions in this Section 6(c) shall apply and supersede
anything to the contrary that may be set forth in the Plan, the Grant Notice or in any other section of this Agreement with respect to the permitted treatment of your Non-Exempt Award: 

(i) Any exercise by the Board of discretion to accelerate the vesting of your Non-Exempt Award shall not result in any
acceleration of the scheduled issuance dates for the Ordinary Shares in respect of the Non-Exempt Award unless earlier issuance of the Ordinary Shares upon the applicable vesting dates would be in compliance with the requirements of
Section 409A. 
 (ii) The Company explicitly reserves the right to (A) earlier settle your Non-Exempt Award to
the extent permitted and in compliance with the requirements of Section 

  
 9. 

 IRELAND 

 
 
409A, including pursuant to any of the exemptions available in Treasury Regulations Section 1.409A-3(j)(4)(ix) and (B) provide that you will receive a cash settlement equal to the Fair
Market Value of the Ordinary Shares that would otherwise be issued to you, if applicable and in compliance with the requirements of Section 409A. 
 (iii) To the extent the terms of your Non-Exempt Award provide that it will be settled upon a Change in Control or Corporate Transaction, to the extent it is required for compliance with the
requirements of Section 409A, the Change in Control or Corporate Transaction event triggering settlement must also constitute a change in the ownership or effective control of the Company, or in the ownership of a substantial portion of the
Company’s assets, Section 409A(a)(2)(A)(v) of the Code and Treasury Regulations Section 1.409A-3(i)(5) (a “409A Change of Control”). To the extent the terms of your Non-Exempt Award provide that it will be
settled upon a termination of employment or termination of Continuous Service, to the extent it is required for compliance with the requirements of Section 409A, the termination event triggering settlement must also constitute a Separation from
Service. However, if at the time the Ordinary Shares would otherwise be issued to you in connection with your Separation from Service, you are subject to the distribution limitations contained in Section 409A applicable to “specified
employees,” as defined in Section 409A(a)(2)(B)(i) of the Code, such Ordinary Shares shall not be issued before the date that is six (6) months following the date of your Separation from Service, or, if earlier, the date of your death
that occurs within such six (6) month period. 
 (iv) The provisions in this Agreement for delivery of the Ordinary
Shares in respect of the Non-Exempt Award are intended to comply with the requirements of Section 409A so that the delivery of the Ordinary Shares to you in respect of your Non-Exempt Award will not trigger the additional tax imposed under
Section 409A, and any ambiguities herein will be so interpreted. 

  
 10.

 IRELAND 

 
 ATTACHMENT II 

JAZZ PHARMACEUTICALS PLC 

2011 EQUITY INCENTIVE PLANEX-10.30

 EXHIBIT 10.30 
 

 
 100 Bayview Circle, Suite 3400 
 Newport Beach, CA 92660 
 www.alliancehealthcareservices-us.com 

May 31, 2012 
 Larry C. Buckelew

 XXXX X. XXX Avenue 
 XXXXXXX XXXXX,
CA XXXXX 
  

	Re:	Appointment as Chairman of the Board and Interim Chief Executive Officer 

 Dear Larry: 
 I am very pleased to offer you the positions of Chairman of the Board of Directors
and Interim Chief Executive Officer of Alliance HealthCare Services, Inc. (“Alliance”). This position reports directly to the Board of Directors (the “Board”). Your appointment will be effective as of June 1, 2012.

 Interim CEO 
 It is mutually
anticipated based on information available at this time that this position will continue for approximately six to twelve months following the effective date of your appointment, the exact length of which will be determined by subsequent agreement
between you and the Board (the length of your employment hereunder, the “Term”). At any time during the Term, either you or the Board may terminate this employment relationship with or without cause by providing at least 30 days prior
written notice. The foregoing agreement regarding the provision of notice of termination notwithstanding, Alliance is an at-will employer; therefore, none of these arrangements (whether communicated in this letter, or otherwise) shall in any way
change your at-will employment status or constitute a guarantee or an employment contract, for a specific term or otherwise. 
 Your
compensation for this position will be an annual amount equal to $1,400,000.00, appropriately pro-rated, subject to withholding obligations and paid in accordance with Alliance’s normal payroll practices. You will not be eligible for an
additional bonus amount. During the Term, you will receive no additional compensation for serving on the Board or committees of the Board. 

You will be eligible to receive an award of up to 500,000 stock options with an exercise price equal to the closing Alliance stock price on your start
date, subject to the terms and conditions of the 1999 Equity Plan for Employees of Alliance Imaging, Inc. and Subsidiaries, as amended, and the Non-Qualified Stock Option Agreement entered into between you and the Company

 May 31, 2012 
 Larry C. Buckelew 
  Page
 2
 
  

 
as of the date of this letter. Subject to the following sentence, these stock options will vest 50% on the date immediately following the first six-month period of your employment, and 50% on the
date immediately following the second six-month period of your employment. In the event that the Board appoints an individual other than you as CEO of Alliance prior to the vesting of all of the 500,000 stock options, the vesting of any such
remaining stock options would then automatically accelerate effective as of the date of such individual’s appointment, provided you remain an employee of the Company through and including such date. 

You will be eligible for four weeks of paid vacation per year as well as all other company benefits, subject to the terms and conditions of each program.
This includes Alliance’s health and welfare plans, as well as the Alliance 401(k) retirement savings plan. 
 Chairman of the Board

 Alliance will pay you a retainer as Chairman of the Board while you serve in such position, but commencing only after the termination or
expiration of the Term described above (the “Retainer Start Date”). You will be eligible to continue as Chairman of the Board following the expiration of the Term, at the sole discretion of the Board. Such retainer will be in addition to
the retainer you would otherwise receive for serving as a member of the Board, and both of which retainers (the “Combined Retainers”) will be paid in aggregate amounts and payment components as follows, subject to the terms and conditions
of both (i) the 1999 Equity Plan for Employees of Alliance Imaging, Inc. and Subsidiaries, as amended, and (ii) a Restricted Stock Unit Agreement to be entered into by and between you and the Company, and paid and vested in a manner
consistent with the normal policies of Alliance: During the first twenty-four months that you are Chairman subsequent to the Retainer Start Date, your Combined Retainers will equal $335,000, $197,500 in cash and $137,500 in RSU awards (calculated by
dividing such amount by the closing trading price of the Company’s common stock on the date of grant). For each full year thereafter during which you remain Chairman, your Combined Retainers will equal $265,000, $162,500 in cash and $102,500 in
RSU awards. The Combined Retainers will be paid only for such periods that you serve as Chairman of the Board, and will cease upon termination of your service as Chairman of the Board for any reason. 

Upon termination or expiration of the Term, you would be eligible, at the sole discretion of the Board, to be reappointed to the Board committee
assignments that you currently hold, subject to the following limitations: First, you will not be eligible to rejoin the Audit Committee unless permitted by all applicable laws, regulations and stock exchange listing standards. Second, in the event
that you serve as Interim CEO for more than 12 months, you will not be eligible to rejoin the Compensation Committee. Third, you would resign as Chairman of the Strategic Planning and Finance Committee. That Chairmanship would then be reassigned to
another Board member, and you would subsequently be eligible to serve, with compensation, as a member of that Committee. Fourth, and finally, as otherwise may then be required by applicable laws, regulations, or stock exchange listing standards.

 General Terms 
 All
interpretations and determinations made by Alliance regarding this offer letter and both positions are conclusive and binding on both parties. By signing below, you acknowledge that 

 May 31, 2012 
 Larry C. Buckelew 
  Page
 3
 
  

 
this letter contains the entire understanding between the parties and supersedes all prior or contemporaneous representations, agreements, arrangements and understandings between them respecting
the subject matter of this letter. 
 If you agree with the terms in this letter, please sign below where indicated and return a copy to me. In
addition, if you have any questions, please feel free to contact me directly. 
 Warmest regards, 

 

	
	 /S/ AARON A. BENDIKSON

	Aaron A. Bendikson
	 Chairman
 Compensation
Committee
 Alliance HealthCare Services, Inc.

 Offer accepted by: 
  

							
	 /S/ LARRY C. BUCKELEW
	 		 	 June 1, 2012
	 	
	Larry C. Buckelew	 		 	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}]]